| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| H Takeuchi, C Borlido, M Sanches, C Teo, L Harber, O Agid, G Remingto. Adherence to clozapine vs. other antipsychotics in schizophrenia. Acta psychiatrica Scandinavica. vol 142. issue 2. 2021-07-12. PMID:32627168. |
adherence to clozapine vs. other antipsychotics in schizophrenia. |
2021-07-12 |
2023-08-13 |
Not clear |
| Emma Wellesley Wesley, India Patel, Giouliana Kadra-Scalzo, Megan Pritchard, Hitesh Shetty, Matthew Broadbent, Aviv Segev, Rashmi Patel, Johnny Downs, James H MacCabe, Richard D Hayes, Daniela Fonseca de Freita. Gender disparities in clozapine prescription in a cohort of treatment-resistant schizophrenia in the South London and Maudsley case register. Schizophrenia research. vol 232. 2021-07-12. PMID:34022618. |
gender disparities in clozapine prescription in a cohort of treatment-resistant schizophrenia in the south london and maudsley case register. |
2021-07-12 |
2023-08-13 |
Not clear |
| Emma Wellesley Wesley, India Patel, Giouliana Kadra-Scalzo, Megan Pritchard, Hitesh Shetty, Matthew Broadbent, Aviv Segev, Rashmi Patel, Johnny Downs, James H MacCabe, Richard D Hayes, Daniela Fonseca de Freita. Gender disparities in clozapine prescription in a cohort of treatment-resistant schizophrenia in the South London and Maudsley case register. Schizophrenia research. vol 232. 2021-07-12. PMID:34022618. |
there has been little research into whether clozapine prescription, the first-line treatment for treatment-resistant schizophrenia (trs), is affected by patient gender. |
2021-07-12 |
2023-08-13 |
Not clear |
| Zoe Harrison, Owen Haeney, William Brereto. Augmentation of Antipsychotic Medications with Low-Dose Clozapine in Treatment-Resistant Schizophrenia-Case Reports and Discussion. Case reports in psychiatry. vol 2021. 2021-07-10. PMID:34239749. |
treatment resistance in schizophrenia is often encountered in clinical practice, with clozapine usually recommended as the appropriate therapy. |
2021-07-10 |
2023-08-13 |
Not clear |
| Renato de Filippis, Raffaele Gaetano, Georgios Schoretsanitis, Giuseppe Verde, Cesare Anthony Oliveti, John M Kane, Cristina Segura-Garcia, Pasquale De Fazi. Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile. Neuropsychiatric disease and treatment. vol 17. 2021-07-09. PMID:34234440. |
clozapine management in schizophrenia inpatients: a 5-year prospective observational study of its safety and tolerability profile. |
2021-07-09 |
2023-08-13 |
Not clear |
| Renato de Filippis, Raffaele Gaetano, Georgios Schoretsanitis, Giuseppe Verde, Cesare Anthony Oliveti, John M Kane, Cristina Segura-Garcia, Pasquale De Fazi. Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile. Neuropsychiatric disease and treatment. vol 17. 2021-07-09. PMID:34234440. |
clozapine is well known for its efficacy and clinical superiority compared to other antipsychotics in treatment-resistant schizophrenia (trs). |
2021-07-09 |
2023-08-13 |
Not clear |
| Yasin Hasan Balcioglu, Hasan Gokcay, Umit Haluk Yesilkay. One Plus One Sometimes Equals More Than Two: Long-acting Injectable Aripiprazole Adjunction in Clozapine-Resistant Schizophrenia. Clinical neuropharmacology. vol 43. issue 5. 2021-07-08. PMID:32947430. |
although we cannot postulate on a single exact mechanism for the increased efficacy of clozapine and aripiprazole combination, we may suggest that, at least for a subgroup of patients with schizophrenia who respond clinically to clozapine at a suboptimal level, combination with aripiprazole may be an effective therapeutic strategy. |
2021-07-08 |
2023-08-13 |
Not clear |
| Maxim Kuzin, Georgios Schoretsanitis, Ekkehard Haen, Florian Ridders, Christoph Hiemke, Gerhard Gründer, Michael Paulze. Pharmacokinetic interactions between clozapine and sertraline in smokers and non-smokers. Basic & clinical pharmacology & toxicology. vol 127. issue 4. 2021-07-06. PMID:32307853. |
clozapine is an effective antipsychotic drug for treatment-resistant schizophrenia. |
2021-07-06 |
2023-08-13 |
Not clear |
| Edward Silva, Melanie Higgins, Barbara Hammer, Paul Stephenso. Clozapine re-challenge and initiation following neutropenia: a review and case series of 14 patients in a high-secure forensic hospital. Therapeutic advances in psychopharmacology. vol 11. 2021-07-06. PMID:34221348. |
clozapine remains the most effective intervention for treatment resistant schizophrenia; however, its use is prohibited following neutropenias. |
2021-07-06 |
2023-08-13 |
Not clear |
| Toshihiro Sato, Masato Suzuka, Yuji Sato, Riko Iwabuchi, Daisuke Kobayashi, Jiro Ogura, Shinya Takasaki, Maki Yokota, Taku Tsukamoto, Yoshihiro Hayakawa, Masafumi Kikuchi, Masamitsu Maekawa, Nariyasu Man. Development of a simultaneous analytical method for clozapine and its metabolites in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry with linear range adjusted by in-source collision-induced dissociation. Biomedical chromatography : BMC. vol 35. issue 7. 2021-07-05. PMID:33599311. |
clozapine (clz) is a key drug in treatment-resistant schizophrenia. |
2021-07-05 |
2023-08-13 |
human |
| Tongtong Zhao, Kai Zhang, Yelei Zhang, Yating Yang, Xiaoshuai Ning, Yu Hu, Xiaoyue Li, Yulong Zhang, Lei Xia, Zhenhua Ren, Huanzhong Li. Do proinflammatory cytokines play a role in clozapine-associated glycometabolism disorders? Psychopharmacology. vol 238. issue 7. 2021-07-05. PMID:33774704. |
clozapine (clz) is the most effective drug for treatment-resistant schizophrenia but is associated with many side effects, including glycometabolism disorders. |
2021-07-05 |
2023-08-13 |
Not clear |
| Xuan Li, Xiaoyun Guo, Xiaoduo Fan, Tienan Feng, Chuanyue Wang, Zhijian Yao, Xiufeng Xu, Zhiyu Chen, Huiling Wang, Shoufu Xie, Jiangjiang He, Kaiming Zhuo, Qiong Xiang, Haixin Cen, Jinhong Wang, Robert C Smith, Hua Jin, Matcheri S Keshavan, Stephen R Marder, John M Davis, Kaida Jiang, Yifeng Xu, Dengtang Li. Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments (SMART-CAT) in first-episode schizophrenia patients: Rationale and trial design. Schizophrenia research. vol 230. 2021-07-02. PMID:33279374. |
we hypothesize that clozapine is more therapeutically effective than any other sgas to patients who failed to meet efficacy criteria in phase 1, and earlier treatment with clozapine can improve the functional outcomes of schizophrenia patients. |
2021-07-02 |
2023-08-13 |
human |
| Xuan Li, Xiaoyun Guo, Xiaoduo Fan, Tienan Feng, Chuanyue Wang, Zhijian Yao, Xiufeng Xu, Zhiyu Chen, Huiling Wang, Shoufu Xie, Jiangjiang He, Kaiming Zhuo, Qiong Xiang, Haixin Cen, Jinhong Wang, Robert C Smith, Hua Jin, Matcheri S Keshavan, Stephen R Marder, John M Davis, Kaida Jiang, Yifeng Xu, Dengtang Li. Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments (SMART-CAT) in first-episode schizophrenia patients: Rationale and trial design. Schizophrenia research. vol 230. 2021-07-02. PMID:33279374. |
it will also provide evidence for the efficacy and safety of using clozapine in the early phase of schizophrenia treatment by comparing with other sgas. |
2021-07-02 |
2023-08-13 |
human |
| Satish Suhas, Vijay Kumar, Ganesan Venkatasubramania. Therapeutic drug monitoring of clozapine in Indian patients with schizophrenia - Authors response. Schizophrenia research. vol 229. 2021-07-02. PMID:33609987. |
therapeutic drug monitoring of clozapine in indian patients with schizophrenia - authors response. |
2021-07-02 |
2023-08-13 |
Not clear |
| Maria Ruiza Yee, Eduardo Espiridon, Adeolu O Oladunjoye, Udema Millsaps, Nailah Harvey, Anish H Vor. The Use of Clozapine in the Serious Mental Illness Patients Enrolled in an Assertive Community Treatment Program. Cureus. vol 13. issue 5. 2021-07-01. PMID:34188983. |
clozapine has shown superior efficacy over first- and most second-generation antipsychotics in both treating treatment-resistant and non-treatment-resistant schizophrenia which has been supported by several large trials. |
2021-07-01 |
2023-08-13 |
Not clear |
| Maria Ruiza Yee, Eduardo Espiridon, Adeolu O Oladunjoye, Udema Millsaps, Nailah Harvey, Anish H Vor. The Use of Clozapine in the Serious Mental Illness Patients Enrolled in an Assertive Community Treatment Program. Cureus. vol 13. issue 5. 2021-07-01. PMID:34188983. |
in fact, clozapine has been approved by the fda for use in refractory schizophrenia and suicidality in schizoaffective disorder. |
2021-07-01 |
2023-08-13 |
Not clear |
| Maria Ruiza Yee, Eduardo Espiridon, Adeolu O Oladunjoye, Udema Millsaps, Nailah Harvey, Anish H Vor. The Use of Clozapine in the Serious Mental Illness Patients Enrolled in an Assertive Community Treatment Program. Cureus. vol 13. issue 5. 2021-07-01. PMID:34188983. |
clozapine remains the gold standard in the treatment of refractory schizophrenia. |
2021-07-01 |
2023-08-13 |
Not clear |
| Sera A J de With, Wai H Man, Coen Maas, Maarten Ten Berg, Wiepke Cahn, Arnold C Koekman, Wouter W van Solinge, Tamar Ta. Neutrophil fluorescence in clozapine users is attributable to a 14kDa secretable protein. Pharmacology research & perspectives. vol 8. issue 5. 2021-06-29. PMID:32812697. |
clozapine is the only antipsychotic agent with demonstrated efficacy in refractory schizophrenia. |
2021-06-29 |
2023-08-13 |
Not clear |
| Jaehyuck P Im, James R Pellegrini, Rezwan Munshi, Leonid Rankov, Amgad N Makaryu. "My Heart Said It's Swollen": A Rare Case of Clozapine-Induced Myocarditis in a Schizophrenic Patient. Cureus. vol 13. issue 5. 2021-06-29. PMID:34178494. |
clozapine is a food and drug administration-approved, second-generation antipsychotic used to treat treatment-resistant schizophrenia. |
2021-06-29 |
2023-08-13 |
Not clear |
| Elias Wagner, William G Honer, Iris E Sommer, Sanne Koops, Daniel M Blumberger, Zafiris J Daskalakis, Jozarni J Dlabac-De Lange, Leonie Bais, Henderikus Knegtering, André Aleman, Tomas Novak, Monika Klirova, Christina Slotema, Jerome Brunelin, Emmanuel Poulet, Milenko Kujovic, Joachim Cordes, Thomas Wobrock, Dan Siskind, Peter Falkai, Thomas Schneider-Axmann, Alkomiet Hasa. Repetitive transcranial magnetic stimulation (rTMS) for schizophrenia patients treated with clozapine. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. vol 22. issue 1. 2021-06-28. PMID:32081071. |
repetitive transcranial magnetic stimulation (rtms) for schizophrenia patients treated with clozapine. |
2021-06-28 |
2023-08-13 |
Not clear |